Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis

By Brunner Jürgen K.H.   Sitzmann Friedrich C.  

Modern Rheumatology, Vol. 16, Iss. 6, 2006-12 ,pp. : 372-375

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of anti‐citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis

By Nakamura H.   Kawakami A.   Ida H.   Origuchi T.   Matsuoka N.   Tsuboi M.   Furuyama M.   Mizokami A.   Tsukada T.   Nakashima M.   Ejima E.   Hamasaki K.   Aoyagi K.   Uetani M.   Fukuda T.   Honda S.   Urayama S.   Kawabe Y.   Ueki Y.   Mine M.   Eguchi K.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 6, 2005-11 ,pp. : 489-490

Informa Healthcare

Access to resources Recommend Favorite

The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis

By Xue Y.   Zhang J.   Chen Y-M.   Guan M.   Zheng S. G.   Zou H-J.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 3, 2008-01 ,pp. : 183-187

Informa Healthcare

Access to resources Recommend Favorite

Association of Anti-cyclic Citrullinated Peptide Antibodies with Clinical and Radiological Disease Severity in Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 10, Iss. 2, 2014-09 ,pp. : 136-143

Bentham Science Publishers

Access to resources Recommend Favorite